• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Integrating Multi-Omics Data Advances Recombinant Protein Yields in Industrial CHO Cells

by
November 13, 2026
in Biology
Reading Time: 7 mins read
0
Integrating Multi-Omics Data Advances Recombinant Protein Yields in Industrial CHO Cells

Integrating Multi-Omics Data Advances Recombinant Protein Yields in Industrial CHO Cells

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Recombinant therapeutic proteins represent an indispensable class of medical treatments, expanding rapidly since the 1987 landmark approval of tissue plasminogen activator produced in mammalian host systems. Today, more than 400 biopharmaceutical products have achieved regulatory approval from the United States Food and Drug Administration, with therapeutic antibodies dominating commercial biomanufacturing. As of 2021, monoclonal antibodies and related antibody formats accounted for 15 of the 20 top-selling pharmaceuticals worldwide, representing an aggregate global market value of approximately $217 billion. Chinese hamster ovary cells serve as the preeminent mammalian expression system, currently responsible for producing over 70 percent of all approved recombinant therapeutic proteins. This industrial predominance stems from several distinct biological advantages: the capacity for large-scale suspension growth in chemically defined, serum-free media; robust genetic tractability achieving titers exceeding 10 grams per liter in fed-batch cultivations; the enzymatic machinery necessary to assemble complex biomolecules with human-like post-translational modifications; and an inherently low susceptibility to human viral propagation, which substantially enhances bioprocess safety.

Despite documented historical gains in commercial manufacturing performance, the fundamental molecular mechanisms coordinating cellular protein factories remain incompletely characterized. Producing recombinant therapeutic proteins involves intricate, sequential biological stages comprising gene transcription, translation, polypeptide folding, structural assembly, intracellular transport, and secretion. While isolated single-omics studies have yielded substantial insight into specific host processes, individual platforms inherently capture only a narrow slice of regulatory biology. Transcriptomics quantifies dynamic changes in messenger RNA abundance but fails to predict downstream protein accumulation or enzymatic activity due to post-transcriptional and translational regulation. Proteomics measures functional cellular effectors yet lacks upstream regulatory context and often suffers from limited dynamic range. Metabolomics captures ultimate phenotypic endpoints without tracing the genetic circuits driving those states, while genomics establishes an organism’s baseline sequence without predicting dynamic biological responses across varied operational conditions. Consequently, a comprehensive review published in Bioresources and Bioprocessing synthesizes global methodologies for integrating genomics, epigenomics, transcriptomics, proteomics, and metabolomics into actionable engineering frameworks across the entire manufacturing pipeline.

Genomic characterization provides the baseline structural blueprint required to comprehend clonal divergence and execute targeted host modifications. Initial genomic research on Chinese hamster ovary cells was severely constrained by the absence of reference sequences until 2011, when the sequencing of the CHO-K1 cell line generated a 2.45-gigabase draft genome encompassing roughly 24,000 annotated genes across 21 chromosomes. Subsequent assembly efforts in 2013 deciphered the Chinese hamster genome, which was substantially refined using hybrid assemblies combining Chinese hamster liver tissue DNA with single-molecule real-time sequencing that resolved 95 percent of previous assembly gaps. By 2020, chromosome-scale conformation capture via Hi-C techniques organized 97 percent of the genomic sequence into 11 large chromosome-scale scaffolds. Currently, the National Center for Biotechnology Information maintains Reference Sequence databases registering 31,247 genes for CHO-K1 and 32,251 genes for the Chinese hamster. Nevertheless, industrial application is tempered by incomplete repetitive element resolution, uncharacterized structural variants under short-read platforms, substantial host-line-specific divergence across unsequenced lineages such as CHO-DG44 and CHO-S, and whole-genome sequencing costs ranging between $500 and $2,000 per sample.

Transcriptomic investigations capture dynamic shifts in cellular RNA populations, encompassing protein-coding transcripts alongside non-coding regulatory elements such as microRNAs and long non-coding RNAs across changing bioreactor environments. Early profiling efforts relied on microarrays adapted from mouse or rat platforms before host-specific microarrays emerged in 2017. However, hybridization-based microarrays could not detect uncharacterized transcripts, low-abundance sequences, or resolve highly homologous genes. Modern sequencing-based RNA sequencing has largely superseded microarrays by providing higher dynamic ranges, lower background noise, and single-nucleotide resolution. Comparative transcriptomics has mapped cellular responses to external bioprocess stresses, including shifts in temperature, pH, dissolved oxygen, and hydrodynamic forces, while illuminating pathways linked to protein secretion and degradation. For example, multi-omics profiling across 95 diverse production cultures revealed that low-producing clones consistently upregulate protein degradation machinery, whereas high-producing variants elevate lipid metabolism and oxidative stress resilience. Concurrently, non-coding RNAs like miR-17, miR-744, Adapt15, and PVT1 have been tied to growth phenotypes, while epitranscriptomic modifications such as N6-methyladenosine have been correlated with elevated protein titers, although definitive causal validation across industrial scales remains a critical bottleneck.

Proteomic profiling delivers the closest molecular readout of functional phenotype by surveying thousands of cellular proteins and post-translational modifications invisible to RNA profiling. Moving away from traditional two-dimensional gel electrophoresis and difference gel electrophoresis, which suffered from limited reproducibility, throughput, and quantitative depth, current investigations rely primarily on liquid chromatography-tandem mass spectrometry. Comprehensive spectral libraries have documented over 10,000 CHO-K1 cellular proteins, enabling deep comparative evaluations among industrial host variants including CHO-K1, CHO-S, CHO-DG44, and CHO-DXB11. These investigations revealed distinct lineage-specific divergence in metabolic regulation, glycosylation machinery, and translational throughput, showing enriched protein synthesis machinery compared to native Chinese hamster tissues. Advanced sub-proteome approaches further dissect cellular architecture: surfaceome analyses uncover hundreds of membrane-bound proteins coordinating extracellular microenvironmental sensing, phosphoproteomics details intracellular signal transduction cascades, and spatial organelle proteomics maps vesicle trafficking machinery through the endoplasmic reticulum and Golgi complex. In parallel, secretome analyses demonstrate that host cells release more than 1,000 distinct proteins into the culture supernatant, with extensive fractions compartmentalized inside extracellular vesicles, presenting clear targets for reducing host cell protein contamination.

Downstream cellular metabolism directly dictates biomass accumulation, culture longevity, and protein productivity through the uptake of nutrients and excretion of metabolic byproducts. Quantitative metabolomics utilizes nuclear magnetic resonance spectroscopy, mass spectrometry, and near-infrared monitoring to track small biochemicals below 1,500 daltons in both intracellular pools and cell-free supernatants. Research tracking metabolic transitions demonstrates that rapid exponential proliferation is characterized by the accumulation of primary glycolytic intermediates, including glucose-6-phosphate, fructose 6-phosphate, and phosphoenolpyruvate, satisfying the intense bioenergetic and biosynthetic requirements of cell division. Conversely, the transition to the stationary production phase coincides with increased concentrations of tricarboxylic acid cycle intermediates, such as citrate, alpha-ketoglutarate, and glutamate, directly correlating with enhanced cell-specific productivity. Targeted feeding studies confirm that exogenous supplementation with tricarboxylic acid intermediates improves overall therapeutic titers. High-producing host cells also exhibit elevated intracellular pools of NADPH, flavin adenine dinucleotide, and reduced glutathione, which sustain endoplasmic reticulum redox balance during high-density protein folding, though metabolomic analysis continues to be challenged by rapid sample turnover, sampling artifacts, and incomplete species-specific spectral libraries.

Epigenomic mechanisms, comprising covalent modifications to chromatin and DNA, dictate long-term transcriptional stability and explain why transgene expression frequently declines over prolonged production regimes. Early studies in transgenic production clones linked recombinant instability directly to promoter silencing mediated by DNA hypermethylation and loss of active histone marks. While repressive chromatin states are established by DNA methylation, histone deacetylation, H3K9me3, and H3K27me3, active transcription is marked by H3K4me3 and H3K27ac. Genome-wide profiling revealed that the CHO DP-12 methylome exhibits global hypomethylation compared to other mammalian systems, with hypermethylation clustered around specific CpG islands. Dynamic tracking demonstrated that stable phenotypes are governed by foundational DNA methylation patterns inherited from the ancestral host lineage, whereas acute cellular adjustments to environmental shifts such as nutrient depletion are orchestrated primarily through dynamic histone mark turnover. Notably, subclones isolated from a single parental host develop divergent epigenetic profiles and expression patterns under identical growth conditions, illustrating that epigenetic divergence represents a major cryptic determinant of clonal performance and manufacturing stability.

To overcome the limitations of isolated datasets, researchers are transitioning from simple pairwise linear regressions and principal component analyses toward integrated network architectures and machine learning algorithms. Network strategies routinely integrate transcriptomic, proteomic, and exometabolomic fluxes into genome-scale metabolic models. From the foundational community model iCHO1766, successive frameworks such as iCHO2291, iCHO2441, and the recently established iCHO3K model—encompassing 11,004 metabolic reactions and 3,597 genes—have provided mechanistic scaffolds to contextualize multi-omics data using constrained algorithms like GIMME, iMAT, and mCADRE. In parallel, protein interaction networks combined with pathway centrality analyses have pinpointed candidate genomic integration safe harbors, verifying loci such as LIG4 and AASS that maintain greater than 95 percent reporter positivity across 40 generations. Concurrently, machine learning algorithms extract predictive rules from large multi-dimensional cohorts; an elastic net regression across 892 cell lines manufacturing 11 distinct antibody configurations identified Cnpy3 as a general cellular stress biomarker negatively correlated with therapeutic yield, while Bayesian models accurately separated high-producing clones using an integrated panel of 4 genes, 8 proteins, and 11 metabolites.

These integrated multi-omics insights directly guide host cell line optimization and targeted functional engineering. Rather than relying on traditional random transgene integration, which results in wide clonal variation and expression instability, semi-targeted transposons and precise site-specific nucleases such as CRISPR/Cas9 direct expression cassettes into transcriptionally active, epigenetically stable safe harbor loci, including Hprt1, Fer1L4, Hipp11, and C12orf35. Functional cell engineering leverages multi-omics datasets to combat process bottlenecks: knocking out pro-apoptotic genes like Bax and Bak or overexpressing protective chaperones like Bcl-2, HSP70, and Beclin-1 delays cell death and extends viable culture duration. Metabolic engineering downregulates lactate dehydrogenase and pyruvate dehydrogenase kinase while upregulating pyruvate carboxylase to mitigate toxic lactate accumulation. Similarly, the CHOGlycoNET database, integrating hundreds of glycan profiles, provides a mechanistic map of Golgi-localized enzymes, facilitating targeted glycoengineering to refine human-like therapeutic glycoforms. Furthermore, secretory pathway bottlenecks are alleviated by overexpressing targeted chaperones and transport machinery, such as XBP-1, PDI, GRP78, and SNAP-23, significantly elevating secretagogue processing capacity.

The integration of multi-omics continues into expression vector optimization and bioprocess control, where empirical trial-and-error is replaced by rational, model-guided strategies. Because conventional viral promoters like cytomegalovirus are susceptible to epigenetic silencing during extended bioreactor runs, transcriptomic surveys have uncovered strong endogenous promoters, including the cold-inducible S100a6 promoter, which enhances hard-to-express protein yields under mild hypothermia. Synthetic biology frameworks also combine omics-identified transcription factor response elements to design synthetic regulatory promoters matching or exceeding viral promoters throughout biphasic processes. Vector untranslated regions, engineered signal peptides, and codon optimization workflows further maximize translation kinetics and export efficiency. In parallel, bioreactor media formulation is guided by metabolomic tracking of amino acid and nutrient depletion, while real-time analytical tools such as Raman spectroscopy and automated flow cytometry are being interfaced with hybrid machine learning models and digital twins. By combining genome-scale mechanistic frameworks with real-time operational inputs, multi-omics integration establishes an evidence-based roadmap for predictive, precision biomanufacturing in industrial Chinese hamster ovary platforms.

Subject of Research: Multi-omics data integration for improving recombinant protein production in Chinese hamster ovary cells

Article Title: Improving recombinant protein productivity in CHO cells via multi-omics data integration

Article References: Shen, Y., Shi, L., Zhang, X., Guo, X., Dong, W.-H., & Wang, T.-Y. (2026). Improving recombinant protein productivity in CHO cells via multi-omics data integration. Bioresources and Bioprocessing, 13(1), Article 124. https://doi.org/10.1186/s40643-026-01123-3

Image Credits: AI Generated

DOI: 10.1186/s40643-026-01123-3

Keywords: Chinese hamster ovary cells, recombinant therapeutic proteins, multi-omics integration, transcriptomics, proteomics, metabolomics, epigenomics, genome-scale metabolic models, bioprocess optimization, cell line engineering, machine learning, safe harbor integration, fed-batch culture, post-translational modifications, single-cell omics, digital twins, CRISPR screening, metabolic engineering

News Source: Juliet Wilcox. (November 13, 2026). Integrating Multi-Omics Data Advances Recombinant Protein Yields in Industrial CHO Cells. Scienmag.

Tags: bioprocess optimizationcell line engineeringChinese hamster ovary cellsCRISPR screeningdigital twinsepigenomicsfed-batch culturegenome-scale metabolic modelsMachine LearningMetabolic engineeringMetabolomicsMulti-omics integrationpost-translational modificationsProteomicsrecombinant therapeutic proteinssafe harbor integrationsingle-cell omicsTranscriptomics
Share12Tweet7Share2ShareShareShare1

Related Posts

Melatonin Alleviates Ochratoxin A Toxicity in Developing Porcine Embryos

Melatonin Alleviates Ochratoxin A Toxicity in Developing Porcine Embryos

November 20, 2026
Clinical Mycobacterium wolinskyi Genome Highlights Diverse Accessory Repertoire and Antimicrobial Resistance

Clinical Mycobacterium wolinskyi Genome Highlights Diverse Accessory Repertoire and Antimicrobial Resistance

November 20, 2026

Unsupervised Flight Tracking Uncovers Five Discrete Movement Modes in Homing Pigeon Flocks

November 20, 2026

Mesenchymal Stem Cell Mitochondrial Transfer Effects Range From Repair to Maladaptive Responses

November 20, 2026

POPULAR NEWS

  • Ethiopian Study Documents 70 Wild Edible Plant Species Across Aseko District

    Ethiopian Study Documents 70 Wild Edible Plant Species Across Aseko District

    29 shares
    Share 12 Tweet 7
  • Meta-Analysis Finds Half of Surveyed Pakistani Populations Report Insomnia Symptoms

    29 shares
    Share 12 Tweet 7
  • Genotype D1 Hepatitis B Virus Protein Mutations Follow Phase-Dependent Structural Shifts

    29 shares
    Share 12 Tweet 7
  • Frequency Ratio Model Outperforms Competing Methods for Himalayan Landslide Susceptibility Mapping

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Paternal Warmth During School Transition Links to Fewer Child Mental Health Difficulties

Mitapivat Boosts Hemoglobin Response in Select Hereditary Hemolytic Anemias in Trials

Autogenous Swine Bacterin Shows No Reduction in Lameness Treatments in Field Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.